Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-COMP in elderly aggressive NHL
NCT00244127Phase 2Unknown
- Sponsor
- Zeneus Pharma Ltd.
- Start
- Oct 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 5
01
Overview
A Phase 2 trial of doxorubicin in non-Hodgkin lymphoma (NHL), sponsored by Zeneus Pharma Ltd.. Status: unknown.
02
Drugs
doxorubicin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00244127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244127.